Ayhan A, Tuncer Z S, Ayhan A
Department of Obstetrics and Gynaecology, Hacettepe University, Faculty of Medicine, Ankara, Turkey.
Aust N Z J Obstet Gynaecol. 1990 Nov;30(4):378-80. doi: 10.1111/j.1479-828x.1990.tb02035.x.
This study includes 278 patients with Stages 1 and 2 cervical cancer subjected to type 3 hysterectomy and lymphadenectomy. The incidence of lymph node metastasis and effect of paraaortic lymphadenectomy on 5-year survival were evaluated. The overall incidences of pelvic and paraaortic lymph node involvement were 24.1% and 8.0%, respectively. The overall 5-year survival rate was 83.8%. The 5-year survival of patients subjected to both pelvic and paraaortic lymphadenectomy was found to be 84.6%; the figure was 80.9% for patients subjected to only pelvic lymphadenectomy. No statistical difference in survival was found between patients with and without paraaortic lymphadenectomy.
本研究纳入了278例接受3型子宫切除术和淋巴结清扫术的1期和2期宫颈癌患者。评估了淋巴结转移发生率以及主动脉旁淋巴结清扫术对5年生存率的影响。盆腔和主动脉旁淋巴结受累的总体发生率分别为24.1%和8.0%。总体5年生存率为83.8%。接受盆腔和主动脉旁淋巴结清扫术的患者5年生存率为84.6%；仅接受盆腔淋巴结清扫术的患者这一数字为80.9%。主动脉旁淋巴结清扫术患者与未进行该手术的患者在生存率上未发现统计学差异。
